Group Room Radio Goes International

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 10 No 3
Volume 10
Issue 3

LOS ANGELES-The Group Room, a weekly syndicated radio call-in talk show about cancer, is expanding internationally after 5 successful years of broadcasting in the United States. Vital Options TeleSupport Cancer Network, the not-for-profit cancer communications, advocacy, and support organization that produces the show, announced that its first live broadcast from Europe took place January 28, 2001, at The Royal Marsden Hospital, London. A broadcast from Paris followed on February 9. Selma R. Schimmel is host of The Group Room and CEO and founder of Vital Options.

LOS ANGELES—The Group Room, a weekly syndicated radiocall-in talk show about cancer, is expanding internationally after 5 successfulyears of broadcasting in the United States. Vital Options TeleSupport CancerNetwork, the not-for-profit cancer communications, advocacy, and supportorganization that produces the show, announced that its first live broadcastfrom Europe took place January 28, 2001, at The Royal Marsden Hospital, London. Abroadcast from Paris followed on February 9. Selma R. Schimmel is host of The GroupRoom and CEO and founder of Vital Options.

Recent Videos
Patients with cancer are subjected to fewer radiotherapy-induced toxicities because of newer, more advanced technologies.
Hosts Manojkumar Bupathi, MD, MS, and Benjamin Garmezy, MD, discuss presentations at ESMO 2025 that may impact bladder, kidney, and prostate cancer care.
Mandating additional immunotherapy infusions may help replenish T cells and enhance tumor penetration for solid tumors, including GI malignancies.
A novel cancer database may assist patients determine what clinical trials they are eligible to enroll on and identify the next best steps for treatment.
Receiving information regarding tumor-associated antigens or mutational statuses from biopsies may help treatment selection in GI malignancies.
An easy-to-access database allows one to see a patient’s cancer stage, prior treatment, and survival outcomes in a single place.
Related Content